标题
Targeting the Endothelin A Receptor in IgA Nephropathy
作者
关键词
-
出版物
Kidney International Reports
Volume 8, Issue 11, Pages 2198-2210
出版商
Elsevier BV
发表日期
2023-08-04
DOI
10.1016/j.ekir.2023.07.023
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- IgA nephropathy: an overview of drug treatments in clinical trials
- (2023) Haresh Selvaskandan et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Long-Term Outcomes in IgA Nephropathy
- (2023) David Pitcher et al. Clinical Journal of the American Society of Nephrology
- Effects of atrasentan on markers of liver function in patients with type 2 diabetes and chronic kidney disease
- (2023) Donald E. Kohan et al. DIABETES OBESITY & METABOLISM
- First do no harm: systemic glucocorticoids should not be used for the treatment of progressive IgA nephropathy
- (2023) Chee Kay Cheung et al. KIDNEY INTERNATIONAL
- Glucocorticoids for IgA nephropathy—pro
- (2023) Yue-Miao Zhang et al. KIDNEY INTERNATIONAL
- Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial
- (2023) Hiddo J L Heerspink et al. LANCET
- Immunoglobulin A nephropathy is characterized by anti-commensal humoral immune responses
- (2022) Elissa G. Currie et al. JCI Insight
- POS-527 A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Atrasentan in Patients with IgA Nephropathy (The ALIGN Study)
- (2022) H. Lambers Heerspink et al. Kidney International Reports
- POS-109 INTERIM RESULTS OF PHASE 1 AND 2 TRIALS TO INVESTIGATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, PHARMACODYNAMICS, AND CLINICAL ACTIVITY OF BION-1301 IN PATIENTS WITH IgA NEPHROPATHY
- (2022) J. Barratt et al. Kidney International Reports
- MO261: Sparsentan, The Dual Endothelin Angiotensin Receptor Antagonist (DEARA), Attenuates Albuminuria and Protects from the Development of Renal Injury to a Greater Extent Than Losartan in the GDDY Mouse Model of IGA Nephropathy: A 16-Week Study
- (2022) Hajime Nagasawa et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Increase in BNP in Response to Endothelin-Receptor Antagonist Atrasentan Is Associated With Incident Heart Failure
- (2022) J. David Smeijer et al. JACC-Heart Failure
- Randomized Phase II JANUS Study of Atacicept in Patients With Immunoglobulin A Nephropathy and Persistent Proteinuria
- (2022) Jonathan Barratt et al. Kidney International Reports
- Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy
- (2022) Jonathan Barratt et al. KIDNEY INTERNATIONAL
- Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials
- (2022) Colin Baigent et al. LANCET
- Empagliflozin in Patients with Chronic Kidney Disease
- (2022) NEW ENGLAND JOURNAL OF MEDICINE
- Randomized Phase 2 Trial of Telitacicept in Patients With IgA Nephropathy With Persistent Proteinuria
- (2022) Jicheng Lv et al. Kidney International Reports
- Endothelin receptor antagonists for the treatment of diabetic and nondiabetic chronic kidney disease
- (2021) J. David Smeijer et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- A pre-specified analysis of the DAPA-CKD trial demonstrates the effects of dapagliflozin on major adverse kidney events in patients with IgA nephropathy
- (2021) David C. Wheeler et al. KIDNEY INTERNATIONAL
- POS-378 SELECTIVE ETA ANTAGONIST ATRASENTAN, RAPIDLY REDUCES ALBUMINURIA AND DOWNREGULATES INTRA-RENAL PRO-INFLAMMATORY AND PRO-FIBROTIC TRANSCRIPTIONAL NETWORKS IN THE GDDY MOUSE MODEL OF SPONTANEOUS IGA NEPHROPATHY
- (2021) A. KING et al. Kidney International Reports
- KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
- (2021) Brad H. Rovin et al. KIDNEY INTERNATIONAL
- Cell profiling of mouse acute kidney injury reveals conserved cellular responses to injury
- (2020) Yuhei Kirita et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- IgA nephropathy: An interesting autoimmune kidney disease
- (2020) Arun Rajasekaran et al. AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- Dapagliflozin in Patients with Chronic Kidney Disease
- (2020) Hiddo J.L. Heerspink et al. NEW ENGLAND JOURNAL OF MEDICINE
- New insights from SONAR indicate adding sodium glucose co-transporter 2 inhibitors to an endothelin receptor antagonist mitigates fluid retention and enhances albuminuria reduction
- (2020) Hiddo J.L. Heerspink et al. KIDNEY INTERNATIONAL
- Proteinuria Reduction as a Surrogate End Point in Trials of IgA Nephropathy
- (2019) Aliza Thompson et al. Clinical Journal of the American Society of Nephrology
- Endothelin receptor-A mediates degradation of the glomerular endothelial surface layer via pathologic crosstalk between activated podocytes and glomerular endothelial cells
- (2019) Kerstin Ebefors et al. KIDNEY INTERNATIONAL
- Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial
- (2019) Hiddo J L Heerspink et al. LANCET
- Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
- (2019) Vlado Perkovic et al. NEW ENGLAND JOURNAL OF MEDICINE
- Epidemiology of IgA Nephropathy: A Global Perspective
- (2018) Francesco Paolo Schena et al. SEMINARS IN NEPHROLOGY
- Role of Mesangial-Podocytic-Tubular Cross-Talk in IgA Nephropathy
- (2018) Joseph C.K. Leung et al. SEMINARS IN NEPHROLOGY
- Dual inhibition of renin-angiotensin-aldosterone system and endothelin-1 in treatment of chronic kidney disease
- (2016) Radko Komers et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Endothelin-1 Induces Proteinuria by Heparanase-Mediated Disruption of the Glomerular Glycocalyx
- (2016) M. Garsen et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Increased APRIL Expression Induces IgA1 Aberrant Glycosylation in IgA Nephropathy
- (2016) Ya-Ling Zhai et al. MEDICINE
- Predictors of Atrasentan-Associated Fluid Retention and Change in Albuminuria in Patients with Diabetic Nephropathy
- (2015) D. E. Kohan et al. Clinical Journal of the American Society of Nephrology
- Current Understanding of the Role of Complement in IgA Nephropathy
- (2015) N. Maillard et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Endothelin and the Glomerulus in Chronic Kidney Disease
- (2015) Matthias Barton et al. SEMINARS IN NEPHROLOGY
- Endothelial mitochondrial oxidative stress determines podocyte depletion in segmental glomerulosclerosis
- (2014) Ilse Daehn et al. JOURNAL OF CLINICAL INVESTIGATION
- Endothelin and endothelin antagonists in chronic kidney disease
- (2014) Donald E Kohan et al. KIDNEY INTERNATIONAL
- Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens
- (2014) Krzysztof Kiryluk et al. NATURE GENETICS
- Evaluation of the Endothelin Receptor Antagonists Ambrisentan, Bosentan, Macitentan, and Sitaxsentan as Hepatobiliary Transporter Inhibitors and Substrates in Sandwich-Cultured Human Hepatocytes
- (2014) Eve-Irene Lepist et al. PLoS One
- Role of collecting duct endothelin in control of renal function and blood pressure
- (2013) Donald E. Kohan AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- -Arrestin-1 Drives Endothelin-1-Mediated Podocyte Activation and Sustains Renal Injury
- (2013) S. Buelli et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Individuals of Pacific Asian origin with IgA nephropathy have an increased risk of progression to end-stage renal disease
- (2013) Sean J. Barbour et al. KIDNEY INTERNATIONAL
- Determination of Severity of Murine IgA Nephropathy by Glomerular Complement Activation by Aberrantly Glycosylated IgA and Immune Complexes
- (2012) Azusa Hashimoto et al. AMERICAN JOURNAL OF PATHOLOGY
- Endothelin-1 and Endothelin A Receptor Immunoreactivity Is Increased in Patients with Diabetic Nephropathy
- (2012) Claudete Maria Zanatta et al. RENAL FAILURE
- Selective Endothelin-A Receptor Antagonism Reduces Proteinuria, Blood Pressure, and Arterial Stiffness in Chronic Proteinuric Kidney Disease
- (2011) Neeraj Dhaun et al. HYPERTENSION
- The Pathophysiology of IgA Nephropathy
- (2011) H. Suzuki et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Genome-wide association study identifies susceptibility loci for IgA nephropathy
- (2011) Ali G Gharavi et al. NATURE GENETICS
- Regulation of Blood Pressure and Salt Homeostasis by Endothelin
- (2011) Donald E. Kohan et al. PHYSIOLOGICAL REVIEWS
- Endothelin-1 Increases Collagen Accumulation in Renal Mesangial Cells by Stimulating a Chemokine and Cytokine Autocrine Signaling Loop
- (2010) Michael S. Simonson et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- HLA Has Strongest Association with IgA Nephropathy in Genome-Wide Analysis
- (2010) J. Feehally et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Effects of Endothelin Receptor Antagonism Relate to the Degree of Renin-Angiotensin System Blockade in Chronic Proteinuric Kidney Disease
- (2009) Neeraj Dhaun et al. HYPERTENSION
- Blood Pressure–Independent Reduction in Proteinuria and Arterial Stiffness After Acute Endothelin-A Receptor Antagonism in Chronic Kidney Disease
- (2009) Neeraj Dhaun et al. HYPERTENSION
- Aberrant IgA1 Glycosylation Is Inherited in Familial and Sporadic IgA Nephropathy
- (2008) A. G. Gharavi et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now